Ebola virus glycoprotein
E1361797
UNEXPLORED
Ebola virus glycoprotein is the surface protein of the Ebola virus responsible for mediating host cell attachment and membrane fusion, and is a primary target for neutralizing antibodies and antiviral therapies.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Ebola virus glycoprotein canonical | 1 |
| Zaire ebolavirus glycoprotein | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T19157591 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ebola virus glycoprotein Context triple: [maftivimab, hasMolecularTarget, Ebola virus glycoprotein]
-
A.
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
-
B.
Taï Forest ebolavirus
Taï Forest ebolavirus is a rare species of ebolavirus known for causing a single documented non-fatal human infection linked to contact with infected chimpanzees in Côte d’Ivoire.
-
C.
Reston ebolavirus
Reston ebolavirus is a species of ebolavirus that primarily infects nonhuman primates and pigs and is notable for being the only known ebolavirus that has caused asymptomatic infections in humans.
-
D.
Ebolavirus
Ebolavirus is a genus of filamentous, enveloped RNA viruses in the Filoviridae family that cause severe and often fatal hemorrhagic fever in humans and other primates.
-
E.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Ebola virus glycoprotein Target entity description: Ebola virus glycoprotein is the surface protein of the Ebola virus responsible for mediating host cell attachment and membrane fusion, and is a primary target for neutralizing antibodies and antiviral therapies.
-
A.
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
-
B.
Taï Forest ebolavirus
Taï Forest ebolavirus is a rare species of ebolavirus known for causing a single documented non-fatal human infection linked to contact with infected chimpanzees in Côte d’Ivoire.
-
C.
Reston ebolavirus
Reston ebolavirus is a species of ebolavirus that primarily infects nonhuman primates and pigs and is notable for being the only known ebolavirus that has caused asymptomatic infections in humans.
-
D.
Ebolavirus
Ebolavirus is a genus of filamentous, enveloped RNA viruses in the Filoviridae family that cause severe and often fatal hemorrhagic fever in humans and other primates.
-
E.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
- F. None of above. chosen
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.